Unclassifiable CD20-negative Testicular Diffuse Large B-cell Lymphoma - 18/06/18
Doi : 10.1016/j.urology.2018.04.019
Pablo Garrido-Abad a, * 
, Luis García-Martín a, Karen Villar-Zarra b, Ariel Díaz- Menéndez b, Manuel Fernández-Arjona a
, Luis García-Martín a, Karen Villar-Zarra b, Ariel Díaz- Menéndez b, Manuel Fernández-Arjona a a Urology Department, Hospital Universitario del Henares, Coslada, Madrid, Spain
b Pathology Department, Hospital Universitario del Henares, Coslada, Madrid, Spain
*Address correspondence to: Pablo Garrido-Abad, M.D., Hospital Universitario del Henares, Avda Marie Curie s.n. 28820, Coslada, Madrid, Spain.Hospital Universitario del HenaresAvda Marie Curie s.n. 28820CosladaMadridSpain
Abstract |
CD20-negative diffuse large B-cell lymphoma (DLBCL) is a very uncommon neoplasm, and very rare unclassifiable cases that did not meet the criteria for well-established subtypes of CD20-negative DLBCLs have been reported. CD20-negative DLBCLs often present an aggressive clinical course with important chemoresistance and poor prognosis. Here, we report a case of CD20-negative DLBCL presented as a testicular mass. To the best of our knowledge, this is one of the first reported cases of testicular unclassifiable CD20-negative DLBCL.
Le texte complet de cet article est disponible en PDF.| Financial Disclosure:The authors declare that they have no relevant financial interests. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 117
P. e3-e4 - juillet 2018 Retour au numéro
Article précédent
- Erosion of Polytetrafluoroethylene (Gore-tex) Sling Over 20 Years After Placement for Stress Urinary Incontinence
- Julie W. Cheng, Andrea Staack
- Arterial Fistula With Severe Hematuria After Ileal Conduit Diversion
- Alessandro Morlacco, Filiberto Zattoni
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?